Old Web
English
Sign In
Acemap
>
authorDetail
>
Stephen R. Dunn
Stephen R. Dunn
Thomas Jefferson University Hospital
Medicine
Internal medicine
Virology
Adefovir
Lamivudine
5
Papers
138
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation.
2014
Cancer Medicine
Hie-Won Hann
Robert Coben
Daniel B. Brown
Laurence Needleman
Ernest L. Rosato
Albert D. Min
Richard S. Hann
Kyong Bin Park
Stephen R. Dunn
Anthony J. DiMarino
Show All
Source
Cite
Save
Citations (28)
Question of ALT flare during switch to adefovir from lamivudine: a single center open-label, randomized, safety study (June 17, 2005 to February 5, 2009).
2010
Journal of Medical Virology
Hie-Won Hann
Stephen R. Dunn
Meejin Ahn
So Young Park
Show All
Source
Cite
Save
Citations (1)
Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV)
2008
Hepatology International
Hie-Won Hann
Hee Bok Chae
Stephen R. Dunn
Show All
Source
Cite
Save
Citations (29)
495 Tenofovir (TNV) has stronger antiviral effect than adefovir dipivoxil (ADV) against lamivudine (LAM) resistant hepatitis B virus (HBV)
2006
Journal of Hepatology
Hie-Won Hann
H. B. Chae
Stephen R. Dunn
Show All
Source
Cite
Save
Citations (7)
A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients
1997
American Journal of Kidney Diseases
William J. Gaughan
Kenneth A. Liss
Stephen R. Dunn
Antonia M. Mangold
Judith P. Buhsmer
Beckie Michael
James F. Burke
Show All
Source
Cite
Save
Citations (73)
1